Ubiquitin-Specific Peptidase 9X Inhibition for Antitumor Immunity Via Programmed Death Ligand 1 Ubiquitination and T-Cell Activation
APOC3-Mediated Fatty Acid Metabolism Suppresses Lung Adenocarcinoma Progression by Inhibiting GNAI3/cAMP/PKA Pathway
mTORC1 Suppression by Trp53 Mutation Drives Resistance to Immune Checkpoint Blockade
Overcoming IGF1R-Mediated Resistance to Oncolytic HSV1 and Radiotherapy via Triple Combination Therapy
CASC19 co-operating with DHX9 Facilitates Gastric Cancer Progression and Metastasis through Inhibiting Ferroptosis and Promoting Immune Evasion
CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling
Exhausted CD8⁺ T Cells Promote Ovarian Cancer Immunosuppression via CCL3-Driven M2 Macrophage Polarization
T-cell engager bispecific antibodies enable T cells to eliminate Multiple Myeloma by targeting tumor CD38 in combination with PD-L1
USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer
Neuromedin U promotes lung adenocarcinoma progression by enhancing nucleotide metabolism and potentiating fibrosis in the tumor microenvironment